LivaNova (LIVN) Income from Non-Controlling Interests (2017)

LivaNova (LIVN) posted Income from Non-Controlling Interests of $1.9 million for Q4 2017, up 334.82% sequentially from -$830000.0 in Q3 2017.

LivaNova (LIVN) Income from Non-Controlling Interests (2017) Analysis & Trends

LivaNova has reported Income from Non-Controlling Interests for 1 years, with the latest figure at $1.9 million in Q4 2017.

Quarterly Income from Non-Controlling Interests changed N/A year-over-year to $1.9 million in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $1.3 million (changed N/A YoY) and the FY2017 annual result came in at $1.3 million, down 98.03% from the prior year.
Income from Non-Controlling Interests improved to $1.9 million in Q4 2017 per LIVN's latest filing, from -$830000.0 in the prior quarter.
Over five years, Income from Non-Controlling Interests peaked at $2.0 million in Q1 2017 and troughed at -$1.8 million in Q2 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inc. Minority (Qtr)
1	Abbott Laboratories	199.77 Bn	194.17 Bn	7.27 Bn	-
2	Stryker	129.56 Bn	126.08 Bn	4.50 Bn	-
3	Medtronic	120.09 Bn	110.87 Bn	6.41 Bn	16.00 Mn
4	Boston Scientific	73.80 Bn	73.26 Bn	3.85 Bn	-2.00 Mn
5	Edwards Lifesciences	52.68 Bn	48.43 Bn	1.35 Bn	-500,000.00
6	Dexcom	34.60 Bn	32.65 Bn	830.00 Mn	-
7	GE HealthCare Technologies	34.10 Bn	31.99 Bn	2.18 Bn	13.00 Mn
8	Koninklijke Philips	26.45 Bn	23.12 Bn	4.55 Bn	2.32 Mn
9	Steris	23.20 Bn	22.72 Bn	684.20 Mn	900,000.00
10	LivaNova	4.35 Bn	3.83 Bn	273.67 Mn	-

Download Data